Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed…
by October Gallery
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed…
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid…
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end…
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency…
FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company’s IPO on the…
(Reuters) – Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its…
(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal…
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File…
(Reuters) – JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in…
NEW YORK/WASHINGTON (Reuters) – U.S. drugmaker Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans…
ZURICH/BENGALURU (Reuters) – New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is…
Vor Abgeben eines Kommentares bitte die Beschreibung lesen! Weniger Fleisch essen ist auf ethischer Ebene genauso wie weniger Vergewaltigung oder…
On October 17, 2017, Tristan Roberts, an activist and software engineer, injected himself with a chemical solution that he hoped…
LONDON (Reuters) – British pharma company AstraZeneca said it had sold the rights for Seroquel, a treatment for schizophrenia and…
(Reuters) – Biohaven Pharmaceutical Holding said its treatment for acute migraine cleared two late-stage studies, but investors worried about its…